全文获取类型
收费全文 | 992篇 |
免费 | 55篇 |
学科分类
医药卫生 | 1047篇 |
出版年
2023年 | 4篇 |
2021年 | 4篇 |
2018年 | 18篇 |
2017年 | 17篇 |
2016年 | 9篇 |
2015年 | 10篇 |
2014年 | 79篇 |
2013年 | 48篇 |
2012年 | 58篇 |
2011年 | 50篇 |
2010年 | 32篇 |
2009年 | 34篇 |
2008年 | 28篇 |
2007年 | 35篇 |
2006年 | 34篇 |
2005年 | 64篇 |
2004年 | 19篇 |
2003年 | 19篇 |
2002年 | 45篇 |
2001年 | 9篇 |
2000年 | 6篇 |
1999年 | 10篇 |
1998年 | 21篇 |
1997年 | 46篇 |
1996年 | 31篇 |
1995年 | 22篇 |
1994年 | 26篇 |
1993年 | 22篇 |
1992年 | 16篇 |
1991年 | 7篇 |
1990年 | 15篇 |
1989年 | 30篇 |
1988年 | 18篇 |
1987年 | 17篇 |
1986年 | 15篇 |
1985年 | 18篇 |
1984年 | 8篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1977年 | 13篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1973年 | 5篇 |
1971年 | 4篇 |
1970年 | 5篇 |
1969年 | 6篇 |
1967年 | 4篇 |
排序方式: 共有1047条查询结果,搜索用时 15 毫秒
91.
D Pathirana A Nast AD Ormerod N Reytan P Saiag CH Smith P Spuls B Rzany 《Journal of the European Academy of Dermatology and Venereology》2010,24(12):1458-1467
Background The development of evidence based guidelines is a demanding and time consuming process. Therefore it is important to share the knowledge and discuss the structure of these guidelines in detail. Objectives To present a method report on the development process of the European evidence based guidelines on the systemic treatment of psoriasis vulgaris with the aim to offer guidance to other guidelines groups with lesser experience and to critically appraise the methodology of the guidelines development process. Methods The guidelines are based on the previously evaluated literature from three European national evidence based guidelines and an additional systematic search and evaluation of new literature. Further steps included a structured consensus conference and a DELPHI procedure to develop the recommendations, as well as several internal and external reviews. All steps were coordinated by the Division of evidence based medicine in cooperation with a group of methodologists. Results A total of 114 studies were included, serving as base for the efficacy chapters of the intervention. The recommendations, based on the efficacy and the level of evidence of the included studies were discussed and finally consented by the guidelines group. After subsequent reviews the guidelines were presented to the European Dermatology Forum, European Academy of Dermatology and Venereology and Union Européenne des Médicins Spécialistes for approval and published in October 2009. Conclusion The development of European evidence based guidelines requires a coordinated structure which can be achieved by the integration of an experienced group of methodologists. Nevertheless further improvements are imaginable and might be considered for an update or other European evidence based guidelines. 相似文献
92.
93.
94.
AD Cohen†‡§ J Dreiher†‡ Y Shapiro¶ L Vidavsky† DA Vardy‡§ B Davidovici J Meyerovitch† †† ‡‡ 《Journal of the European Academy of Dermatology and Venereology》2008,22(5):585-589
Background Previous reports have shown an association between psoriasis and the metabolic syndrome, but there are only a few studies on the association between psoriasis and diabetes. Objectives To study the association between psoriasis and diabetes. Methods A cross‐sectional study was performed utilizing the database of Clalit Health Services (CHS). Patients who were diagnosed with psoriasis were compared with CHS enrolees without psoriasis regarding the prevalence of diabetes. Patients with diabetes were identified using the CHS chronic diseases registry. Chi‐squared tests were used to compare categorical parameters. Logistic regression models were used for multivariate analyses. Results The study included 16 851 patients with psoriasis and 74 987 subjects without psoriasis (control patients). The proportion of diabetes was significantly higher in patients above 35 years (P < 0.05). The age‐adjusted proportion of diabetes was significantly higher in psoriasis patients as compared to the control group [odds ratio (OR), 1.38, P < 0.05] and was similar in men and women (OR, 1.32, 1.45, respectively). A multivariate logistic regression model showed that psoriasis was significantly associated with diabetes, independently of age and gender (OR, 1.58, P < 0.001). Conclusions Our study supports previous reports of an association between psoriasis and diabetes. Dermatologists taking care of patients with psoriasis should be aware of this association and advise the patients to reduce additional risk factors such as smoking, hypertension or dyslipidemia. 相似文献
95.
96.
97.
The early biochemical and hormonal profile of patients with long bone fractures at risk of fat embolism syndrome 总被引:1,自引:0,他引:1
Free fatty acids (FFA) are believed to play a role in the genesis of the fat embolism syndrome (FES). Levels of plasma FFA, glucose, insulin, and the stress hormones cortisol, growth hormone, prolactin, glucagon, and catecholamines were measured on admission to hospital in: a) 14 patients with long bone fractures at risk of developing FES, b) 14 patients with soft-tissue injuries of comparable severity, and c) 20 healthy fasting subjects. The findings were similar in both groups of injured patients and in keeping with the hormonal and substrate responses to the stress of trauma; plasma FFA levels were raised but in neither group was the rise pronounced. Plasma FFA levels of the fracture patients were only moderately higher than the values of the healthy fasting subjects. These findings suggest that mobilized FFA from peripheral adipose tissue are not important in the genesis of the FES, but do not exclude a role for FFA derived mainly from hydrolysis of triglyceride emboli in the lung. 相似文献
98.
99.
100.
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia 总被引:1,自引:0,他引:1
Korbling M; Hunstein W; Fliedner TM; Cayeux S; Dorken B; Fehrentz D; Haas R; Ho AD; Keilholz U; Knauf W 《Blood》1989,74(6):1898-1904
Autologous bone marrow transplantation (ABMT) makes it possible to escalate the dose of cytotoxic treatment to a lethal range. Disease- free survival (DFS) following myeloablative therapy and ABMT has been shown to be superior to conventional treatment in high risk patients with acute myelogenous leukemia (AML). It was the purpose of the present study to compare hematopoietic reconstitution, actuarial DFS, and relapse rate of patients transplanted in first complete remission (CR) of AML with those in second or subsequent CR, and to evaluate transplant related mortality. Fifty-two patients with AML, 22 in first CR (low risk) and 30 in second or subsequent CR (high risk), underwent total body irradiation (12.1 to 16.7 Gy) and cyclophosphamide (CY) treatment (200 mg/kg) followed by ABMT. The autograft was incubated with the active CY derivative Mafosfamide (ASTA Werke, Bielefeld, Federal Republic of Germany) to reduce the number of possibly contaminating clonogenic tumor cells. All patients showed three lineage engraftments with platelet recovery observed as being the slowest. The transplant related death rate was low at 5.8%. There was no significant difference in the kinetics of polymorphonuclear (PMN) cell or platelet reconstitution between the low and high risk patient subgroups. The estimated probability of DFS (relapse) after ABMT in first CR was 61% (36%) compared with 34% (65%) in second or subsequent CR, the longest follow-up being 55 months and 57 months, respectively (median follow-up 31 months and 19 months, respectively). ABMT offers a stable long-term DFS when performed in first CR with no relapses occurring in over a year after transplantation. Six later relapses, however, were seen after ABMT in second or subsequent CR, although DFS was not statistically different from that of first remission patients (P = .72). 相似文献